Quick Answer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Total Revenue of $4.02 billion for fiscal year 2025.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $4.02B | -0.9% |
| 2024 | $4.05B | -1.9% |
| 2023 | $4.13B | +3.9% |
| 2022 | $3.98B | +12.3% |
| 2021 | $3.54B | +21.1% |
| 2020 | $2.92B | +11.5% |
| 2019 | $2.62B | +15.7% |
| 2018 | $2.27B | +22.0% |
| 2017 | $1.86B | +10.5% |
| 2016 | $1.68B | +23.3% |
| 2015 | $1.36B | +5.1% |
| 2014 | $1.30B | +11.3% |
| 2013 | $1.17B | +3.2% |
| 2012 | $1.13B | -1.1% |
| 2011 | $1.14B | +0.8% |
| 2010 | $1.13B | -3.3% |
| 2009 | $1.17B | -9.5% |
| 2008 | $1.30B | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.00B | -0.5% | -2.6% |
| June 30, 2025 | $1.03B | +0.6% | +4.9% |
| March 31, 2025 | $984.17M | -2.7% | -2.5% |
| September 30, 2024 | $1.01B | -1.6% | -1.6% |
| June 30, 2024 | $1.03B | -3.2% | +1.4% |
| March 31, 2024 | $1.01B | -1.7% | -1.5% |
| September 30, 2023 | $1.03B | +3.8% | -3.1% |
| June 30, 2023 | $1.06B | +8.9% | +3.0% |
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -0.9% in Total Revenue compared to the prior fiscal year.
- Over the 2008–2025 period, CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s total revenue has grown by 210.0% (from $1.30 billion to $4.02 billion).
- The most recent figure is from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: